Streetbeat News

Stock Prices

MKL

Markel Corporation (NYSE:MKL) is scheduled to release its quarterly earnings report on January 31, 2024. Analysts predict an EPS of $21.36. Investors are looking for an earnings beat and positive guidance for future growth. Historically, Markel's stock price has been sensitive to earnings performance, with a 12.82% drop after missing EPS last quarter. Over the past year, MKL shares have increased by 6.38%, with current trading at $1492.69.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 3:01 pm

APTV

Aptiv (NYSE:APTV) is scheduled to release its quarterly earnings report on January 31, 2024. Analysts predict an EPS of $1.32. Investors are looking for an earnings beat and positive guidance for the next quarter. Aptiv's stock performance has been negative over the last year, with shares down 23.89%. Historical data shows mixed reactions to past earnings reports, with minor share price changes following the announcements.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 3:01 pm

MAXN

Maxeon Solar Technologies (NASDAQ:MAXN) received mixed analyst ratings with 3 bullish, 1 somewhat bullish, and 7 indifferent. The average 12-month price target is $9.45, down 39.03% from the previous target. Analysts from firms like Mizuho, Goldman Sachs, Morgan Stanley, UBS, Roth MKM, Northland Capital Markets, and Raymond James have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Maxeon is engaged in manufacturing and marketing solar technology, with a market cap below industry average, a negative revenue trend, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 3:00 pm

GIB

CGI (NYSE:GIB) is expected to release its quarterly earnings report on Wednesday, 2024-01-31, with analysts predicting an EPS of $1.36. Investors are looking for an earnings beat and positive guidance for future growth. Last quarter, CGI beat EPS estimates by $0.04, leading to a slight stock increase. Shares are currently trading at $110.5, up 18.28% over the past year, indicating a positive sentiment among long-term shareholders ahead of the earnings release.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 3:00 pm

SOLUSD

Solana's (CRYPTO: SOL) price has increased by 9.69% in the last 24 hours, reaching $105.22, and has seen a 29.0% gain over the past week. The coin's all-time high is $259.96. Trading volume has risen by 8.0% over the past week, and the circulating supply has increased by 1.42% to over 435.50 million. Solana's current market cap is $45.86 billion, ranking it #5.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 3:00 pm

NEXI

NexImmune (NEXI) shares have resumed trading. There is no additional context provided in the article to explain why trading was halted or what might have caused it to resume.

Portfolio Pulse from Benzinga Newsdesk

January 30, 2024 | 2:58 pm

MSCI

MSCI Inc (NYSE:MSCI) reported a strong fourth-quarter FY23 with revenue growth of 19.8% Y/Y to $690.11 million, surpassing consensus estimates. Adjusted EPS was $3.68, also above expectations. The company saw increases in run-rate, retention rate, and operating revenues across various segments, including Index, Analytics, ESG and Climate, and Private Assets. The operating margin was stable, and adjusted EBITDA margin improved. MSCI ended the quarter with significant free cash flow and cash reserves. CEO Henry A. Fernandez highlighted a decade of growth and record achievements. MSCI anticipates FY24 operating expenses between $1.30 billion and $1.34 billion, capex of $95 million to $105 million, and free cash flow of $1.225 billion to $1.285 billion. MSCI shares rose by 8.81% to $599.48.

Portfolio Pulse from Anusuya Lahiri

January 30, 2024 | 2:57 pm

PBLA

Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares dropped over 2% on Tuesday after a 65.3% decline on Monday. The company announced an abstract for SBP-101 was accepted for a poster presentation at the American Association for Cancer Research. Panbela is collaborating with Johns Hopkins University School of Medicine on this. Additionally, Panbela disclosed the pricing of a public offering of 4.38 million shares or pre-funded warrants, with two classes of warrants to purchase up to 8.75 million shares. The common warrants have an exercise price of $2.06 per share and are exercisable immediately, expiring in five years. The offering aims to raise approximately $9.0 million and is expected to close by January 31, 2024. Last week, Panbela was in news for enrolling in the ASPIRE global clinical trial for metastatic pancreatic cancer treatment.

Portfolio Pulse from Nabaparna Bhattacharya

January 30, 2024 | 2:56 pm

BABA

HLPPY

LGFRY

MCHI

TECHY

Chinese stock markets continued their decline with the Hang Seng index dropping 2.3% and the Shanghai Composite by 1.8%. Hang Lung Properties and Longfor Properties saw significant losses. Despite a short-selling ban by the China Securities Regulatory Commission, the sell-off persisted, driven by investors exiting the market rather than hedge funds. U.S.-listed ETFs like the iShares MSCI China ETF experienced net outflows, with MCHI losing a third of its value over the past year. Market analysts attribute the downturn to political factors and trade tensions rather than economic issues. Tim Seymour expressed a cautious stance on China, highlighting state control over companies like Tencent and Alibaba.

Portfolio Pulse from Neil Dennis

January 30, 2024 | 2:55 pm

LCID

Lucid Group Inc (NASDAQ:LCID) shares dropped Tuesday morning after a 27% rally on Monday. The decline follows a broader EV sector weakness, influenced by Tesla's disappointing financial results. Lucid's upcoming Q4 financial report is expected to show a loss of 29 cents per share. A new partnership with Ma'aden Rolling for aluminum sheets and the appointment of Matt Everitt as General Counsel are recent positive developments. Technical analysis suggests Lucid's stock is below its 200-day moving average, indicating a bearish signal.

Portfolio Pulse from Adam Eckert

January 30, 2024 | 2:48 pm